RIVA-ISMN DIN 02570742
Health Canada record
| Active ingredient(s) | ISOSORBIDE-5-MONONITRATE 60 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | ETHICAL |
| Class | Human |
| ATC | C01DA14 ISOSORBIDE MONONITRATE |
| Original market date | |
| Current status date | 07-Aug-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoire Riva Inc. — licence 100179, currently licensed, last inspection rating C (2026-01-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ISOSORBIDE-5-MONONITRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02272830 | APO-ISMN | APOTEX INC | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed |
| 02301288 | PMS-ISMN | PHARMASCIENCE INC | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed |
| 02311321 | PRO-ISMN - 60 | PRO DOC LIMITEE | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed |
| 02562561 | PRZ-ISMN | PHARMARIS CANADA INC | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Marketed |
| 02307758 | DOM-ISMN | DOMINION PHARMACAL | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Cancelled Pre Market |
| 02126559 | IMDUR | JUNO PHARMACEUTICALS CORP. | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Dormant |
| 02446073 | ISMN | SIVEM PHARMACEUTICALS ULC | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Cancelled Post Market |
| 02058472 | ISMO TAB 20MG | WYETH-AYERST CANADA INC. | Tablet | ISOSORBIDE-5-MONONITRATE 20 MG | Cancelled Post Market |
| 02307731 | PHL-ISMN | PHARMEL INC | Tablet (Extended-Release) | ISOSORBIDE-5-MONONITRATE 60 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38069 | 2026-08-10 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for ISOSORBIDE-5-MONONITRATE
1 active FDA Drug Master Files.
Request a quote for RIVA-ISMN